mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.33 |
0.02 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |